MedPath

Robotic versus open pelvic exenterations for pelvic cancer - a multicenter propensity-matched analysis in Japa

Not Applicable
Recruiting
Conditions
pelvic cancer
D010386
Registration Number
JPRN-jRCT1030230163
Lead Sponsor
Kinugasa Yusuke
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
449
Inclusion Criteria

Patients who underwent total pelvic exenteration (TPE), Anterior pelvic exenteration (APE), posterior pelvic exenteration (PPE) for pelvic malignant tumor between January 2012 and October 2022 were included.

Exclusion Criteria

Those patients who did not diagnosed as a histologically malignant, who had not been of declared of their cancer, or who refused to participate in the study were excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the complication rate of over C-D grade IIIA
Secondary Outcome Measures
NameTimeMethod
Duration of operation (min), Intraoperative blood loss (ml), Intraoperative transfusion, Resection margin status,Conversion to open surgery, In-hostital death, Death within 30 days, Morbidity within 30 days, Morbidity within 90days
© Copyright 2025. All Rights Reserved by MedPath